Evidence map›Paper›PMID 30864244›Full record

ArticleThoracic cancer2019

Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancy.

Matthew Koslow, David Shitrit, Lilach Israeli-Shani, Orit Uziel, Einat Beery, Alexandra Osadchy, Yael Refaely, Gali Epstein Shochet, Aliza Amiel

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Matthew KoslowAdvanced Lung Disease and Transplant Program, INOVA Fairfax Hospital, Falls Church, Virginia USA.ORCID 0000-0001-5974-714X
David ShitritPulmonary Medicine Department, Meir Medical Center, Kfar Saba, Israel.
Lilach Israeli-ShaniPulmonary Medicine Department, Meir Medical Center, Kfar Saba, Israel.
Orit UzielSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Einat BeeryThe Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.
Alexandra OsadchyDiagnostic Imaging Department, Meir Medical Center, Kfar Saba, Israel.
Yael RefaelySurgical Department, Soroka Medical Center, Beer-Sheva, Israel.
Gali Epstein ShochetPulmonary Medicine Department, Meir Medical Center, Kfar Saba, Israel.ORCID 0000-0002-3417-9171
Aliza AmielSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tel Aviv University · ILInova Fairfax Hospital · USMeir Medical Center · ILRabin Medical Center · ILSoroka Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A ground glass opacity (GGO) lung lesion may represent early stage adenocarcinoma, which has an excellent prognosis upon prompt surgical resection. However, GGO lesions have broad differential diagnoses, including both benign and malignant lesions. Our objective was to study telomere length and telomerase activity in patients with suspected lung cancer in which GGO was the predominant radiographic feature. Knowledge of telomere biology may help distinguish malignant from benign radiographic lesions and guide risk assessment of these lesions. Peripheral blood samples were taken from 22 patients with suspected adenocarcinoma with the GGO radiographic presentation. Multidisciplinary discussion confirmed the need for surgery in all cases. We used an age and gender-matched group without known lung disease as a control. Telomere length and aggregates were assessed by quantitative fluorescence in situ hybridization (QFISH) and quantitative PCR. Cell senescence was evaluated by senescence-associated heterochromatin foci. Subjects with GGO lesions had a higher percentage of lymphocytes with shorter telomeres (Q-FISH, P = 0.003). Furthermore, relative telomere length was also reduced among the GGO cases (qPCR, P < 0.05). Increased senescence was observed in the GGO group compared to controls (P < 0.001), with significant correlation between the senescence-associated heterochromatin foci and aggregate formation (r = -0.7 and r = -0.44 for cases and controls, respectively). In conclusion, patients with resectable early adenocarcinoma demonstrate abnormal telomere length and cell senescence in peripheral blood leukocytes compared to control subjects. Abnormal telomere biology in the peripheral blood may increase suspicion of early adenocarcinoma among patients with GGO lesions.

Indexed as

Adenocarcinoma of LungAgedCellular SenescenceDiagnosis, DifferentialFemaleHumansIn Situ Hybridization, FluorescenceLeukocytes, MononuclearLungMaleTelomereTelomere HomeostasisAdenocarcinomablood markerGGOsenescencetelomere

Identifiers

PMID30864244
PMCPMC6449235
OpenAlexW2921249661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.